Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts (B.L.B., A.S.).
George Washington University Milken Institute School of Public Health, Washington, DC (S.F.W.).
Ann Intern Med. 2021 Jan;174(1):105-106. doi: 10.7326/M20-6671. Epub 2020 Oct 21.
This article discusses the risk evaluation and mitigation strategy (REMS) program imposed by the Food and Drug Administration for mifepristone.
本文讨论了食品和药物管理局对米非司酮实施的风险评估和缓解策略 (REMS) 计划。